Identification of essential genes for cancer immunotherapy
Shashank J. Patel(National Institutes of Health), Nicholas P. Restifo(Lyell Immunopharma (United States))
Cited by 890
Related Papers
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
|Nature Clinical Practice Oncology|2006|348
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
|JCI Insight|2017|221
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
|Stem Cell Research & Therapy|2020|42